| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Annals of Surgical Oncology, Vol 5, Issue 3 271-278, Copyright © 1998 by Society of Surgical Oncology
ARTICLES |
J. H. Harmey, E. Dimitriadis, E. Kay, H. P. Redmond and D. Bouchier-Hayes
Royal College of Surgeons in Ireland, Department of Surgery, Beaumont Hospital, Dublin.
BACKGROUND: Breast tumors contain high numbers of infiltrating macrophages. The role and function of these cells within the tumor remain unclear, but a number of studies have found an association between poor prognosis and macrophage content in human breast cancer. Both hypoxia and TGFbeta-1 have been shown to regulate VEGF in other cell types. We hypothesized that breast tumor-associated macrophages produce VEGF and that macrophage production of this factor is regulated by both hypoxia and TGFbeta-1. METHODS: Paraffin-embedded breast tumor sections were stained immunohistochemically with anti-VEGF, anti-CD68, and anti-cytokeratin. Monocytes were matured for 3 days in 20% autologous plasma and activated with 1000 U/mL interferon-gamma for 24 hours. Supernatants were assayed for VEGF protein by ELISA. Total RNA was isolated from cells and reverse transcribed to cDNA, which was used as a template in PCR reactions for VEGF and beta-actin. RESULTS: Both tumor cells and tumor macrophages produce VEGF in human breast tumors. Hypoxia increases VEGF protein and mRNA levels in monocyte-derived macrophages, whereas TGFbeta-1 increases VEGF protein but not mRNA under hypoxic growth conditions. CONCLUSIONS: Breast tumor-associated macrophages may contribute to the angiogenic activity of human breast tumors by producing VEGF. Macrophage production of VEGF is upregulated by hypoxia and TGFbeta-1, both of which occur in the tumor environment. Macrophage production of VEGF is regulated at both the mRNA and protein levels.
This article has been cited by other articles:
![]() |
C. Lamagna, M. Aurrand-Lions, and B. A. Imhof Dual role of macrophages in tumor growth and angiogenesis J. Leukoc. Biol., October 1, 2006; 80(4): 705 - 713. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Lewis and C. Murdoch Macrophage Responses to Hypoxia: Implications for Tumor Progression and Anti-Cancer Therapies Am. J. Pathol., September 1, 2005; 167(3): 627 - 635. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Adams, K. Lenk, A. Linke, D. Lenz, S. Erbs, M. Sandri, A. Tarnok, S. Gielen, F. Emmrich, G. Schuler, et al. Increase of Circulating Endothelial Progenitor Cells in Patients with Coronary Artery Disease After Exercise-Induced Ischemia Arterioscler. Thromb. Vasc. Biol., April 1, 2004; 24(4): 684 - 690. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Trisciuoglio, A. Iervolino, A. Candiloro, G. Fibbi, M. Fanciulli, U. Zangemeister-Wittke, G. Zupi, and D. Del Bufalo bcl-2 Induction of Urokinase Plasminogen Activator Receptor Expression in Human Cancer Cells through Sp1 Activation: INVOLVEMENT OF ERK1/ERK2 ACTIVITY J. Biol. Chem., February 20, 2004; 279(8): 6737 - 6745. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Burke, A. Giannoudis, K. P. Corke, D. Gill, M. Wells, L. Ziegler-Heitbrock, and C. E. Lewis Hypoxia-Induced Gene Expression in Human Macrophages: Implications for Ischemic Tissues and Hypoxia-Regulated Gene Therapy Am. J. Pathol., October 1, 2003; 163(4): 1233 - 1243. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Sakurai, A. Anand, B. K. Ambati, N. van Rooijen, and J. Ambati Macrophage Depletion Inhibits Experimental Choroidal Neovascularization Invest. Ophthalmol. Vis. Sci., August 1, 2003; 44(8): 3578 - 3585. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Sakurai, H. Taguchi, A. Anand, B. K. Ambati, E. S. Gragoudas, J. W. Miller, A. P. Adamis, and J. Ambati Targeted Disruption of the CD18 or ICAM-1 Gene Inhibits Choroidal Neovascularization Invest. Ophthalmol. Vis. Sci., June 1, 2003; 44(6): 2743 - 2749. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Lavie, H. Kraiczi, A. Hefetz, H. Ghandour, A. Perelman, J. Hedner, and P. Lavie Plasma Vascular Endothelial Growth Factor in Sleep Apnea Syndrome: Effects of Nasal Continuous Positive Air Pressure Treatment Am. J. Respir. Crit. Care Med., June 15, 2002; 165(12): 1624 - 1628. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. C. G. LEE, D. MELKERNEKER, P. J. THOMPSON, R. W. LIGHT, and K. B. LANE Transforming Growth Factor beta Induces Vascular Endothelial Growth Factor Elaboration from Pleural Mesothelial Cells in Vivo and in Vitro Am. J. Respir. Crit. Care Med., January 1, 2002; 165(1): 88 - 94. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Crowther, N. J. Brown, E. T. Bishop, and C. E. Lewis Microenvironmental influence on macrophage regulation of angiogenesis in wounds and malignant tumors J. Leukoc. Biol., October 1, 2001; 70(4): 478 - 490. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. A. Foekens, H. A. Peters, N. Grebenchtchikov, M. P. Look, M. E. Meijer-van Gelder, A. Geurts-Moespot, T. H. van der Kwast, C. G. J. Sweep, and J. G. M. Klijn High Tumor Levels of Vascular Endothelial Growth Factor Predict Poor Response to Systemic Therapy in Advanced Breast Cancer Cancer Res., July 1, 2001; 61(14): 5407 - 5414. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. E. Gargett, F. Lederman, B. Heryanto, L. S. Gambino, and P. A.W. Rogers Focal vascular endothelial growth factor correlates with angiogenesis in human endometrium. Role of intravascular neutrophils Hum. Reprod., June 1, 2001; 16(6): 1065 - 1075. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Matsubayashi, Y. Matsuo, G. Edakuni, T. Satoh, O. Tokunaga, and S. Kudo Breast Masses with Peripheral Rim Enhancement on Dynamic Contrast-enhanced MR Images: Correlation of MR Findings with Histologic Features and Expression of Growth Factors Radiology, December 1, 2000; 217(3): 841 - 848. [Abstract] [Full Text] |
||||
![]() |
R. A. Mesa, C. A. Hanson, S. V. Rajkumar, G. Schroeder, and A. Tefferi Evaluation and clinical correlations of bone marrow angiogenesis in myelofibrosis with myeloid metaplasia Blood, November 15, 2000; 96(10): 3374 - 3380. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. E. Kroon, P. Koolwijk, B. van der Vecht, and V. W. M. van Hinsbergh Urokinase receptor expression on human microvascular endothelial cells is increased by hypoxia: implications for capillary-like tube formation in a fibrin matrix Blood, October 15, 2000; 96(8): 2775 - 2783. [Abstract] [Full Text] [PDF] |
||||
![]() |
W Li and G Keller VEGF nuclear accumulation correlates with phenotypical changes in endothelial cells J. Cell Sci., January 5, 2000; 113(9): 1525 - 1534. [Abstract] [PDF] |
||||
![]() |
M. McCourt, J. H. Wang, S. Sookhai, and H. P. Redmond Proinflammatory Mediators Stimulate Neutrophil-Directed Angiogenesis Arch Surg, December 1, 1999; 134(12): 1325 - 1331. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Schultz, L. Lavie, I. Hochberg, R. Beyar, T. Stone, K. Skorecki, P. Lavie, A. Roguin, and A. P. Levy Interindividual Heterogeneity in the Hypoxic Regulation of VEGF : Significance for the Development of the Coronary Artery Collateral Circulation Circulation, August 3, 1999; 100(5): 547 - 552. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Meeson, M Argilla, K Ko, L Witte, and R. Lang VEGF deprivation-induced apoptosis is a component of programmed capillary regression Development, January 4, 1999; 126(7): 1407 - 1415. [Abstract] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |